Literature DB >> 22090318

Antimicrobial de-escalation in cancer patients.

K V I Rolston, S N Mahajan, R F Chemaly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22090318     DOI： 10.1007/s15010-011-0221-6

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  7 in total

1.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

Review 2.  Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; John S Bradley; John E Edwards; David Gilbert; Louis B Rice; Michael Scheld; Brad Spellberg; John Bartlett
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

3.  De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.

Authors:  N Shime; S Satake; N Fujita
Journal:  Infection       Date:  2011-04-21       Impact factor: 3.553

4.  Challenges in the treatment of infections caused by gram-positive and gram-negative bacteria in patients with cancer and neutropenia.

Authors:  Kenneth V I Rolston
Journal:  Clin Infect Dis       Date:  2005-04-01       Impact factor: 9.079

5.  Incidence of fluoroquinolone-resistant and extended-spectrum β-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States.

Authors:  Y Bhusal; C N Mihu; J J Tarrand; K V Rolston
Journal:  Chemotherapy       Date:  2011-09-06       Impact factor: 2.544

6.  Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer.

Authors:  Norio Ohmagari; Hend Hanna; Linda Graviss; Brenda Hackett; Cheryl Perego; Virginia Gonzalez; Tanya Dvorak; Holly Hogan; Ray Hachem; Kenneth Rolston; Issam Raad
Journal:  Cancer       Date:  2005-07-01       Impact factor: 6.860

7.  Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america.

Authors:  Alison G Freifeld; Eric J Bow; Kent A Sepkowitz; Michael J Boeckh; James I Ito; Craig A Mullen; Issam I Raad; Kenneth V Rolston; Jo-Anne H Young; John R Wingard
Journal:  Clin Infect Dis       Date:  2011-02-15       Impact factor: 9.079
  7 in total
  2 in total

1.  De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Infection       Date:  2012-12-20       Impact factor: 3.553

2.  Determinants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study.

Authors:  Nawal Salahuddin; Lama Amer; Mini Joseph; Alya El Hazmi; Hassan Hawa; Khalid Maghrabi
Journal:  Crit Care Res Pract       Date:  2016-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.